Economist David C. Datelle says the pharmaceutical industry's prices have less to do with innovation than with corporate ...

The need to address the high cost of prescription drugs is one of the rare areas of concordance in our divided country. Americans across the political spectrum can agree that seniors shouldn’t have to ...

The news comes on the heels of President Trump calling for Congress to enact his most recent attempt to lower healthcare costs in America, The Great Healthcare Plan. The proposal is a series of ...

With Johnson & Johnson’s participation, 15 of 17 companies contacted by the administration over the summer have now signed on. Earlier deals had been announced with Pfizer, AstraZeneca, EMD Serono, ...

For moms, nothing matters more than our families’ health. But for too many families, staying healthy has become unaffordable. Health ...

Trump unveiled a new healthcare plan that calls for lower drug prices, reduced insurance premiums and price transparency.

Pharmaceutical research and development (R&D) is unlikely to be significantly impacted by most favored nation (MFN) pricing, according to industry experts. The US bears the highest drug costs globally ...

The city of Springfield is following in the steps of other large employers in filing suit against manufacturers of diabetes ...

The tariffs might be aimed at Europe, but they’re going to hit American pocketbooks.

The suit claims price-gouging by manufacturers and says the companies operated out of greed.